The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by CIBC Asset Management Inc

CIBC Asset Management Inc lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,321 shares of the medical device company’s stock after buying an additional 1,328 shares during the quarter. CIBC Asset Management Inc’s holdings in Cooper Companies were worth $2,787,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. State Street Corp raised its stake in shares of Cooper Companies by 1.2% during the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock worth $947,897,000 after buying an additional 104,521 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after purchasing an additional 573,908 shares during the last quarter. Geode Capital Management LLC raised its stake in Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock valued at $527,476,000 after purchasing an additional 48,559 shares during the last quarter. Victory Capital Management Inc. raised its stake in Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after purchasing an additional 737,726 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after purchasing an additional 194,118 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Up 2.6 %

Shares of NASDAQ:COO opened at $88.69 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The stock has a market capitalization of $17.70 billion, a P/E ratio of 45.48, a PEG ratio of 2.21 and a beta of 1.00. The stock has a 50-day simple moving average of $93.07 and a 200-day simple moving average of $99.57.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the previous year, the business earned $0.87 EPS. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analyst Weigh In

COO has been the subject of several analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Morgan Stanley cut their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company boosted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.